Long-Term Effects on Growth and Hormonal Outcomes of Feeding Low-Protein Infant Formula Enriched with α-Lactalbumin or Reduced in Casein Glycomacropeptide During Early Infancy: A Follow-Up Study

Background: High protein intake during infancy has been associated with accelerated weight gain and increased risk of later obesity through insulin and insulin-like growth factor 1 (IGF-1) pathways. Objective: We aimed to investigate whether growth and metabolic outcomes closer to those of breastfed infants (BF) up to 12 months in the ALFoNS trial persisted during early childhood in children fed modified low-protein formulas (LPFs) during the first half of infancy compared to those fed standard formula (SF). Methods: In this randomized controlled trial (RCT), 245 formula-fed infants (FF) were randomized to SF (2.2 g protein/100 kcal) or one of two LPFs—either α-lactalbumin-enriched whey (α-lac-EW; 1.75 g protein/100 kcal) or casein glycomacropeptide-reduced whey (CGMP-RW; 1.76 g protein/100 kcal) between 2 and 6 months—with 83 BF infants as a non-randomized reference group. In the present study, children were followed up at 18, 36, and 60 months with assessment of anthropometry, nutrient intake and analyses of serum insulin, C-peptide, IGF-1 and hemoglobin at 18 months. Results: At 18 months, weight and body mass index (BMI) were significantly higher among SF compared with BF infants (p < 0.05), but with no differences between LPF groups and the BF group. The prevalence of overweight at 18 months was higher in the SF (0.014) and CGMP-RW (p = 0.016) groups, but not in α-lac-EW group (p = 0.054) compared with the BF group, while no significant differences were found between the FF groups. No differences in growth were observed between the groups at 36 or 60 months. Serum insulin, C-peptide, and IGF-1 did not differ significantly between the groups at 18 months. Conclusions: Feeding LPFs during early infancy was associated with growth patterns more similar to those of BF infants at 18 months of age, than if fed higher protein formula, but with no growth differences at 3 or 5 years.

Authors

Institutions

Publication Details

Journal
Nutrients
Published
2026-11-16
DOI
https://doi.org/10.3390/nu18223810
Primary Topic
Infant Nutrition and Health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Long-Term Effects on Growth and Hormonal Outcomes of Feeding Low-Protein Infant Formula Enriched with α-Lactalbumin or Reduced in Casein Glycomacropeptide During Early Infancy: A Follow-Up Study

Ελένη Κορδή, Carolyn M. Slupsky, Olle Hernell, Bo L Lönnerdal et al.
2 links
Nutrients
Infant Nutrition and Health
article

Long-Term Effects on Growth and Hormonal Outcomes of Feeding Low-Protein Infant Formula Enriched with α-Lactalbumin or Reduced in Casein Glycomacropeptide During Early Infancy: A Follow-Up Study

Ελένη Κορδή, Carolyn M. Slupsky, Olle Hernell, Bo L Lönnerdal, Maria Nunez‐Salces, Xuan He, Lotte Neergaard Jacobsen, Pia Karlsland Åkeson, Ulrika Tinghäll Nilsson
article en

Abstract

Background: High protein intake during infancy has been associated with accelerated weight gain and increased risk of later obesity through insulin and insulin-like growth factor 1 (IGF-1) pathways. Objective: We aimed to investigate whether growth and metabolic outcomes closer to those of breastfed infants (BF) up to 12 months in the ALFoNS trial persisted during early childhood in children fed modified low-protein formulas (LPFs) during the first half of infancy compared to those fed standard formula (SF). Methods: In this randomized controlled trial (RCT), 245 formula-fed infants (FF) were randomized to SF (2.2 g protein/100 kcal) or one of two LPFs—either α-lactalbumin-enriched whey (α-lac-EW; 1.75 g protein/100 kcal) or casein glycomacropeptide-reduced whey (CGMP-RW; 1.76 g protein/100 kcal) between 2 and 6 months—with 83 BF infants as a non-randomized reference group. In the present study, children were followed up at 18, 36, and 60 months with assessment of anthropometry, nutrient intake and analyses of serum insulin, C-peptide, IGF-1 and hemoglobin at 18 months. Results: At 18 months, weight and body mass index (BMI) were significantly higher among SF compared with BF infants (p < 0.05), but with no differences between LPF groups and the BF group. The prevalence of overweight at 18 months was higher in the SF (0.014) and CGMP-RW (p = 0.016) groups, but not in α-lac-EW group (p = 0.054) compared with the BF group, while no significant differences were found between the FF groups. No differences in growth were observed between the groups at 36 or 60 months. Serum insulin, C-peptide, and IGF-1 did not differ significantly between the groups at 18 months. Conclusions: Feeding LPFs during early infancy was associated with growth patterns more similar to those of BF infants at 18 months of age, than if fed higher protein formula, but with no growth differences at 3 or 5 years.

NutrientsVol. 18(22)
Lund University (SE), Arla Foods (Denmark) (DK), University of California, Davis (US), Umeå University (SE)
Arla Foods Ingredients Group
Good health and well-being, Zero hunger
Infant Nutrition and Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon